Urolithiasis — the formation of calculi within the urinary collecting system — is one of the most common urological conditions worldwide, with a lifetime prevalence of approximately 10–15% in developed countries and a high recurrence rate of 30–50% within five years after the first episode. Renal colic, the acute severe flank pain caused by ureteral obstruction from a passing stone, is one of the most frequent presentations to emergency departments globally. Non-contrast CT (NCCT) of the abdomen and pelvis has become the gold standard for diagnosing suspected urolithiasis, replacing intravenous urography (IVU) due to its superior sensitivity (95–98%) and specificity (96–100%), rapid acquisition time, and ability to diagnose alternative conditions when no stone is found.

Why Non-Contrast CT for Kidney Stones?

The choice of non-contrast (unenhanced) CT for urolithiasis evaluation is not arbitrary — it is driven by CT physics. All urinary tract calculi, regardless of their chemical composition, are denser than surrounding soft tissues and appear hyperdense (bright white) on non-contrast CT. Iodinated intravenous contrast, if administered, would obscure small stones in the opacified collecting system and ureter — making stone detection paradoxically more difficult. NCCT therefore maximizes stone conspicuity while simultaneously revealing all secondary signs of ureteral obstruction and alternative diagnoses in a single rapid examination.

CT Protocol: Low-Dose is the Standard of Care

Given the young age of many urolithiasis patients and the frequency of recurrence requiring repeat imaging, radiation dose minimization is a critical priority. Low-dose CT (LDCT) protocols with 60–80% dose reduction compared to standard abdominal CT have been validated for kidney stone detection, with no significant loss of diagnostic accuracy for stones greater than 3 mm in diameter. Ultra-low-dose CT (sub-millisievert protocols) are increasingly used in lean patients and for follow-up imaging after treatment. The scan range covers from the top of the kidneys (above the upper poles) to the bladder base in the pelvis — encompassing the entire urinary tract.

CT Findings of Urolithiasis: The Primary Signs

The primary CT finding is a hyperdense focus within the urinary tract — the kidney, renal pelvis, ureter, or bladder. Essential measurements for each stone include: location (renal calyx, renal pelvis, ureteropelvic junction, proximal ureter, mid-ureter, ureterovesical junction, or intraluminal in bladder); maximum diameter in millimetres (the single most important measurement for predicting spontaneous passage — stones less than 4 mm pass spontaneously in over 80% of cases, stones greater than 8 mm rarely pass without intervention); and Hounsfield unit (HU) density — which predicts stone composition and guides shock wave lithotripsy (SWL) success (stones greater than 1000 HU are typically calcium oxalate monohydrate and may be harder to fragment with SWL).

Secondary Signs of Ureteral Obstruction

Beyond the stone itself, CT demonstrates the consequences of urinary obstruction, which correlate with clinical severity and guide management urgency. Secondary signs include: Hydronephrosis — dilatation of the renal pelvis and calyces proximal to the obstructing stone; Hydroureter — dilatation of the ureter proximal to the obstructing calculus; Perinephric fat stranding — hazy increased density in the fat surrounding the kidney, indicating forniceal rupture and extravasation of urine or inflammatory edema; Renal enlargement — ipsilateral kidney swelling due to increased pressure; and the Tissue Rim Sign — a thin soft-tissue rim surrounding the stone within the ureter, representing edematous ureteral wall — which helps distinguish a ureteral stone from a phlebolith (pelvic vein calcification, a common mimic).

Stone Composition and the Dual-Energy CT Advantage

Standard single-energy CT cannot reliably determine stone chemical composition (uric acid, calcium oxalate, calcium phosphate, struvite, cystine). This is clinically important because uric acid stones — the only radiolucent calculi on plain X-ray — can be dissolved with oral urine alkalinization therapy (potassium citrate), potentially avoiding invasive treatment. Dual-energy CT (DECT) exploits the differential attenuation of tissues at two different X-ray energies to generate material decomposition maps. On DECT, uric acid stones display characteristic low density on high-energy images and can be reliably differentiated from calcium-containing stones — a powerful non-invasive approach to stone composition analysis that directly informs clinical management strategy.